©The Author(s) 2016.
World J Gastrointest Endosc. Nov 16, 2016; 8(19): 716-722
Published online Nov 16, 2016. doi: 10.4253/wjge.v8.i19.716
Published online Nov 16, 2016. doi: 10.4253/wjge.v8.i19.716
Table 1 Backgrounds of the patients and endoscopic submucosal dissection results n (%)
| Vonoprazan (n = 14) | Lansoprazole (n = 12) | P value | |
| Backgrounds | |||
| Age (yr) | 71.9 ± 7.9 | 74.8 ± 8.3 | 0.371 |
| Sex (M/F) | 12/2 | 10/2 | 0.867 |
| Anticoagulants | 1 (7.1) | 1 (8.3) | 0.910 |
| Antiplatelet agents | 3 (21.4) | 3 (21.4) | 0.829 |
| Steroids | 1 (7.1) | 0 (0) | 0.345 |
| Helicobacter pylori infection | 4 (28.6) | 5 (0.417) | 0.484 |
| Atrophic gastritis | |||
| Closed type | 3 (21.4) | 0 (0) | 0.088 |
| Open type | 11 (78.6) | 12 (100.0) | |
| Location | |||
| Upper | 1 | 0 | 0.618 |
| Middle | 5 | 4 | |
| Lower | 8 | 8 | |
| ESD results | |||
| En bloc resection | 14 (100.0) | 12 (100.0) | |
| Procedure time (min) | 88 (36-246) | 51.5 (12-202) | 0.123 |
| Submucosal fibrosis | 3 (25.0) | 1 (8.3) | 0.356 |
| Histopathology | |||
| Tub1 | 12 | 10 | 0.504 |
| Tub1 + tub2 | 1 | 2 | |
| Tub1 + tub2 + por2 | 1 | 0 |
- Citation: Takahashi K, Sato Y, Kohisa J, Watanabe J, Sato H, Mizuno K, Hashimoto S, Terai S. Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers. World J Gastrointest Endosc 2016; 8(19): 716-722
- URL: https://www.wjgnet.com/1948-5190/full/v8/i19/716.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i19.716